Artelo BiosciencesARTL
13F holders, Q1 2026 (March 31)10holders
$7.58avg. 13F price*
At the end of Q1 2026, 10 institutions reported holding Artelo Biosciences Inc. (ARTL) in their 13F filings. The largest holders were Kathmere Capital Management, LLC ($100K), Jane Street Group, LLC ($99K) and Vanguard Capital Management LLC ($77K).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G706
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $245K |
| Exits | 0 | $0 |
Ownership 10 holders
| Kathmere Capital Management, LLC | 0.01% | New | 13,250 | $100K |
| Jane Street Group, LLC | 0.00% | New | 13,079 | $99K |
| Vanguard Capital Management LLC | 0.00% | — | 10,129 | $77K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 3,139 | $24K |
| Citigroup Inc. | 0.00% | New | 3,076 | $23K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,826 | $21K |
| Clear Street Group Inc. | 0.00% | New | 100 | $758 |
| Rothschild Investment LLC | 0.00% | New | 2 | $15 |
| Cwm, LLC | 0.00% | New | 1 | $8 |
| Osaic Holdings, Inc. | 0.00% | New | 1 | $7 |
"% of holder's portfolio" is ARTL's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.